Paolo Giovanni Casali

11PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Economic models and forecastingEpidemiological modellingPredictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|Jan 24, 2026
Medical decision analysis for personalized oncology at the patient bedside.

Paolo G Casali, Lisa Licitra, Salvatore Provenzano

|Sep 16, 2024
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

Silvia Stacchiotti, Silvia Martini, Sandro Pasquali

|Jan 17, 2024
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo

|Sep 12, 2023
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.

Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni

|Nov 14, 2022
Is rare cancer care organized at national health system level? Multiple case study in six EU countries.

Joan Prades, Annalisa Trama, Paolo G Casali

Pageof 2

Frequent Collaborators

3 joint publications

Alessandro Gronchi

3 joint publications

Paolo Verderio

3 joint publications

Roberta Sanfilippo

3 joint publications

Sandro Pasquali